Merck strikes $10B deal to buy Verona Pharma

Verona Pharma brings to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive pulmonary disease. While Ohtuvayre is projected to become a blockbuster product in COPD alone, its potential extends to other respiratory disorders as well.

Editor's Pick

Top Story Merck Breathes Life into Its Respiratory Prospects With $10B Deal to Buy Verona Pharma Verona Pharma brings to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive pulmonary disease. While Ohtuvayre is projected to become a blockbuster product in COPD alone, its potential extends to other respiratory disorders as well. Sponsored Is Your Healthcare Organization Overconfident About Email Security? Presented by Paubox A new Paubox report reveals critical gaps in healthcare email security—and why AI-powered phishing threats are exposing dangerous overconfidence. Discover what your organization may be missing and how to stay HIPAA compliant. Take action today! Meet the Future of Digital Health MedCity INVEST Digital Health is happening September 18 in Dallas — where startups, investors, and healthcare leaders converge to shape what's next. 🎤 Expert panels. 🤝 Curated networking. 🚀 Live startup pitches. Register Now

Featured News

Is Your AI-Driven Healthcare Startup Ready for New Investment? Apply to INVEST Digital Health Pitch Perfect Today. We're getting close to the July 19 deadline for submissions. Don't miss this opportunity to pitch your company to a team of investors at INVEST Digital Health in Dallas on September 18! MedCity Pivot Podcast: Why Blood Pressure Monitoring Is Due for A New Era [Sponsored] CoraVie Medical CEO Aimee Garza and Dr. Michael Bloch, a hypertension specialist and clinical advisor for the startup, talk about why the healthcare industry needs a better approach to blood pressure monitoring. CoraVie is developing an implantable device that measures patients' blood pressure, operating in a similar way to continuous glucose monitors. Watch or listen now! Mandatory by 2026: 5 Ways to Prepare for CMS' TEAM Payment Model For hospitals and health systems, the challenge is steep, but so is the opportunity. TEAM offers a framework to deliver more coordinated, cost-effective, and patient-focused care. Those who prepare now will be far better positioned to thrive in a value-based future. Beyond the Prescription: Supporting Long-Term Metabolic Health After GLP-1s GLP-1s are a breakthrough, but they are not the end of the story. To ensure lasting success, we must pair pharmacological interventions with behavioral support, personalized data, and continuous guidance.

Video   Women's Health Isn't Just About Reproductive Issues About 70% of investment in women's health goes towards wellness and reproductive issues — but that's not a holistic view of women's health, noted Amani Bright of Springboard Enterprises. She thinks more understanding of the full scope of women's health will lead to more investment. After all, women make up half of the population, so there is a huge investment opportunity when it comes to women's health outside of the scope of reproductive organs, Bright said.

Sponsored Expert Care in Houston: Top-Rated Hand and Wrist Surgeons You Can Trust Presented by Fondren Orthopedic Group Too many people sacrifice their quality of life by putting off a surgical procedure. Discover the top-rated hand and wrist surgeons in the Houston area who can help. Learn More.

Resources

MedCity FemFwd: Inside Springboard Enterprises and Accenture's New Women's Health Report In this episode, we're joined by Julia Lasater, management consulting senior analyst at Accenture, and Amani Bright, senior program manager at Springboard Enterprises. They discuss the key takeaways of their recent women's health report. Watch now!

MedCity News • PO Box 901 • New York, NY unsubscribe